Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Indivior (Nasdaq/LSE: INDV) has scheduled its second quarter 2025 financial results announcement for July 31, 2025 at 7:00 a.m. U.S. ET. Following the financial release, CEO Joe Ciaffoni and the leadership team will host a live webcast presentation at 8:00 a.m. U.S. ET.
Investors can access the webcast and presentation materials through the company's website at www.indivior.com. The event will also be accessible via telephone, with registration required for dial-in details. A replay of the presentation will be made available on the company's website afterward.
Details
News Market Reaction – INDV
The recorded move for INDV in the trading session of this news was +3.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins.
The webcast link: https://edge.media-server.com/mmc/p/ro37758v
Participants may access the presentation telephonically by registering with the following link:
https://register-conf.media-server.com/register/BIb74823c247374ec38580055874599386
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com.
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-to-report-second-quarter-2025-financial-results-and-host-webcast-on-july-31st-302507909.html
SOURCE Indivior PLC
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.